Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer NCT05415709 Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Serous ...
Primary Periton...
Primary Periton...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Carboplatin
Cisplatin
Cytoreductive S...
Hyperthermic In...
Paclitaxel
Quality-of-Life...
Questionnaire A...
18 Years - Ohio State University Comprehensive Cancer Center View Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery NCT03943173 BRCA-Mutated Ov...
BRCA1 Gene Muta...
BRCA2 Gene Muta...
High Grade Fall...
High Grade Ovar...
Primary Periton...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Chemotherapy
Olaparib
Therapeutic Con...
18 Years - M.D. Anderson Cancer Center View IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801 Advanced Endome...
Advanced Head a...
Advanced Malign...
Advanced Melano...
Advanced Ovaria...
Chondrosarcoma
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Recurrent Ovari...
Refractory Endo...
Refractory Head...
Refractory Mela...
Refractory Ovar...
Refractory Ovar...
Stage III Ovari...
Stage III Uteri...
Stage IIIA Ovar...
Stage IIIA Uter...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Ovar...
Stage IIIB Uter...
Stage IIIC Ovar...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Ovaria...
Stage IV Uterin...
Stage IVA Ovari...
Stage IVA Uteri...
Stage IVB Ovari...
Stage IVB Uteri...
Bevacizumab
Glutaminase-1 I...
Paclitaxel
Capivasertib
18 Years - M.D. Anderson Cancer Center View Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer NCT04491942 Advanced Bile D...
Advanced Breast...
Advanced Cervic...
Advanced Endome...
Advanced Esopha...
Advanced Gastri...
Advanced Head a...
Advanced Lung N...
Advanced Lung S...
Advanced Malign...
Advanced Ovaria...
Advanced Penile...
Advanced Pleura...
Advanced Urothe...
Anatomic Stage ...
Anatomic Stage ...
Clinical Stage ...
Clinical Stage ...
Stage III Cervi...
Stage III Dista...
Stage III Intra...
Stage III Lung ...
Stage III Ovari...
Stage III Penil...
Stage III Pleur...
Stage IV Cervic...
Stage IV Distal...
Stage IV Intrah...
Stage IV Lung C...
Stage IV Ovaria...
Stage IV Penile...
Stage IV Pleura...
Triple-Negative...
Unresectable Ur...
Cisplatin
Elimusertib
Gemcitabine Hyd...
18 Years - National Cancer Institute (NCI) View Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients NCT05047926 Advanced Ovaria...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Behavioral Coun...
Nutritional Sup...
Physical Activi...
Survey Administ...
Computed Tomogr...
Biospecimen Col...
Health Educatio...
Medical Device ...
18 Years - Mayo Clinic View Developing a Test for the Detection of Ovarian Cancer NCT04794322 Ovarian Neoplas...
Ovarian Epithel...
Fallopian Tube ...
High Grade Ovar...
Stage I Ovarian...
Stage II Ovaria...
Stage III Ovari...
Stage IIIA Ovar...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Ovar...
Stage IIIC Ovar...
Stage IV Ovaria...
Stage IVA Ovari...
Stage IVB Ovari...
Uterine lavage,...
Blood sample
Pap smear
30 Years - Massachusetts General Hospital View Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV NCT04514484 Advanced Differ...
Advanced Head a...
Advanced Hepato...
Advanced Kaposi...
Advanced Lung N...
Advanced Lung S...
Advanced Malign...
Advanced Melano...
Advanced Ovaria...
Advanced Prosta...
Advanced Renal ...
Advanced Thyroi...
Advanced Triple...
Advanced Urothe...
Anatomic Stage ...
Anatomic Stage ...
Castration-Resi...
Clinical Stage ...
Clinical Stage ...
HIV Infection
Metastatic Diff...
Metastatic Head...
Metastatic Hepa...
Metastatic Kapo...
Metastatic Lung...
Metastatic Lung...
Metastatic Mali...
Metastatic Mela...
Metastatic Ovar...
Metastatic Pros...
Metastatic Rena...
Metastatic Thyr...
Metastatic Trip...
Metastatic Urot...
Recurrent Diffe...
Recurrent Head ...
Recurrent Hepat...
Recurrent Kapos...
Recurrent Lung ...
Recurrent Lung ...
Recurrent Malig...
Recurrent Melan...
Recurrent Ovari...
Recurrent Prost...
Recurrent Renal...
Recurrent Thyro...
Recurrent Tripl...
Recurrent Uroth...
Refractory Diff...
Stage III Diffe...
Stage III Hepat...
Stage III Lung ...
Stage III Ovari...
Stage III Prost...
Stage III Renal...
Stage III Thyro...
Stage IV Differ...
Stage IV Hepato...
Stage IV Lung C...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Thyroi...
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI) View ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer NCT05368506 Advanced Fallop...
Advanced Ovaria...
Advanced Primar...
Anatomic Stage ...
Metastatic Trip...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Wee1 Inhibitor ...
18 Years - OHSU Knight Cancer Institute View Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373 Advanced Breast...
Advanced Endome...
Advanced Fallop...
Advanced Hepato...
Advanced Malign...
Advanced Malign...
Advanced Malign...
Advanced Ovaria...
Advanced Primar...
Advanced Renal ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Malignant Abdom...
Malignant Solid...
Metastatic Brea...
Metastatic Endo...
Metastatic Fall...
Metastatic Hepa...
Metastatic Mali...
Metastatic Mali...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Metastatic Rena...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage III Fallo...
Stage III Hepat...
Stage III Ovari...
Stage III Prima...
Stage III Renal...
Stage III Uteri...
Stage IIIA Fall...
Stage IIIA Hepa...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA Uter...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Hepa...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIB Uter...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Fallop...
Stage IV Hepato...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Renal ...
Stage IV Uterin...
Stage IVA Fallo...
Stage IVA Hepat...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVA Uteri...
Stage IVB Fallo...
Stage IVB Hepat...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Atezolizumab
Cabozantinib S-...
Nab-paclitaxel
Tumor Treating ...
18 Years - M.D. Anderson Cancer Center View Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial NCT05554367 Malignant Solid...
Ovarian Low Gra...
Pancreatic Carc...
Stage IV Ovaria...
Stage IV Pancre...
Binimetinib
Biopsy
Biospecimen Col...
Bone Scan
Computed Tomogr...
Magnetic Resona...
Palbociclib
18 Years - National Cancer Institute (NCI) View Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer NCT04673448 Anatomic Stage ...
Anatomic Stage ...
BRCA-Associated...
BRCA-Associated...
Metastatic BRCA...
Metastatic Brea...
Metastatic Fall...
Metastatic Mali...
Metastatic Ovar...
Metastatic Panc...
Metastatic Prim...
Prognostic Stag...
Prognostic Stag...
Stage III Fallo...
Stage III Ovari...
Stage III Pancr...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Primar...
Unresectable Br...
Unresectable Fa...
Unresectable Ma...
Unresectable Ov...
Unresectable Pa...
Unresectable Pr...
Dostarlimab
Niraparib
18 Years - University of Washington View Developing a Test for the Detection of Ovarian Cancer NCT04794322 Ovarian Neoplas...
Ovarian Epithel...
Fallopian Tube ...
High Grade Ovar...
Stage I Ovarian...
Stage II Ovaria...
Stage III Ovari...
Stage IIIA Ovar...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Ovar...
Stage IIIC Ovar...
Stage IV Ovaria...
Stage IVA Ovari...
Stage IVB Ovari...
Uterine lavage,...
Blood sample
Pap smear
30 Years - Massachusetts General Hospital View ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer NCT05368506 Advanced Fallop...
Advanced Ovaria...
Advanced Primar...
Anatomic Stage ...
Metastatic Trip...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Wee1 Inhibitor ...
18 Years - OHSU Knight Cancer Institute View Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study NCT03707574 Advanced Malign...
Advanced Melano...
Advanced Renal ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage III Color...
Stage III Lung ...
Stage III Ovari...
Stage III Prost...
Stage IIIA Colo...
Stage IIIA Lung...
Stage IIIA Ovar...
Stage IIIA Pros...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Colo...
Stage IIIB Lung...
Stage IIIB Ovar...
Stage IIIB Pros...
Stage IIIC Colo...
Stage IIIC Lung...
Stage IIIC Ovar...
Stage IIIC Pros...
Stage IV Colore...
Stage IV Lung C...
Stage IV Ovaria...
Stage IV Prosta...
Stage IVA Color...
Stage IVA Lung ...
Stage IVA Ovari...
Stage IVA Prost...
Stage IVB Color...
Stage IVB Lung ...
Stage IVB Ovari...
Stage IVB Prost...
Stage IVC Color...
Biospecimen Col...
18 Years - National Cancer Institute (NCI) View Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT03735589 Stage II Fallop...
Stage II Ovaria...
Stage II Primar...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA Prima...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIB Prima...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Alpha-type-1 Po...
Autologous Natu...
18 Years - Roswell Park Cancer Institute View PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer NCT04329494 Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Malignant Uteri...
Metastatic Appe...
Metastatic Colo...
Metastatic Gast...
Metastatic Mali...
Metastatic Mali...
Metastatic Ovar...
Pathologic Stag...
Peritoneal Carc...
Postneoadjuvant...
Stage IV Append...
Stage IV Colore...
Stage IV Ovaria...
Stage IV Uterin...
Stage IVA Appen...
Stage IVA Color...
Stage IVA Ovari...
Stage IVA Uteri...
Stage IVB Appen...
Stage IVB Color...
Stage IVB Ovari...
Stage IVB Uteri...
Stage IVC Appen...
Stage IVC Color...
Biopsy
Cisplatin
Doxorubicin
Fluorouracil
Intraperitoneal...
Irinotecan
Leucovorin
Mitomycin
Oxaliplatin
Quality-of-Life...
Questionnaire A...
18 Years - City of Hope Medical Center View Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors NCT04616534 Advanced Fallop...
Advanced Malign...
Advanced Ovaria...
Advanced Pancre...
Advanced Primar...
Fallopian Tube ...
Metastatic Panc...
Ovarian High Gr...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Primary Periton...
Stage II Pancre...
Stage III Fallo...
Stage III Ovari...
Stage III Pancr...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Primar...
Unresectable Pa...
Biopsy
Biospecimen Col...
Diagnostic Imag...
Elimusertib
Gemcitabine
18 Years - National Cancer Institute (NCI) View Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers NCT03968406 Malignant Femal...
Recurrent Cervi...
Recurrent Endom...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Recurrent Vagin...
Stage IV Cervic...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IV Vagina...
Stage IVA Cervi...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVA Uteri...
Stage IVA Vagin...
Stage IVB Cervi...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Stage IVB Vagin...
Quality-of-Life...
Radiation Thera...
Talazoparib
18 Years - M.D. Anderson Cancer Center View CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000 Advanced Biliar...
Advanced Colore...
Advanced Gastro...
Advanced Lung A...
Advanced Malign...
Advanced Ovaria...
Advanced Pancre...
Advanced Urothe...
Clinical Stage ...
Clinical Stage ...
Metastatic Bili...
Metastatic Colo...
Metastatic Gast...
Metastatic Lung...
Metastatic Ovar...
Metastatic Panc...
Metastatic Urot...
Refractory Bili...
Refractory Colo...
Refractory Gast...
Refractory Lung...
Refractory Ovar...
Refractory Panc...
Refractory Urot...
Stage II Pancre...
Stage III Color...
Stage III Lung ...
Stage III Ovari...
Stage III Pancr...
Stage IV Colore...
Stage IV Lung C...
Stage IV Ovaria...
Stage IV Pancre...
Biospecimen Col...
Computed Tomogr...
Devimistat
Fluorouracil
Gemcitabine Hyd...
Hydroxychloroqu...
Magnetic Resona...
18 Years - Northwestern University View Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability NCT03428802 BRCA1 Gene Muta...
BRCA2 Gene Muta...
Locally Advance...
Metastatic Mali...
POLD1 Gene Muta...
POLE Gene Mutat...
Recurrent Malig...
Recurrent Ovari...
Stage III Breas...
Stage III Ovari...
Stage IIIA Brea...
Stage IIIA Ovar...
Stage IIIB Brea...
Stage IIIB Ovar...
Stage IIIC Brea...
Stage IIIC Ovar...
Stage IV Breast...
Stage IV Ovaria...
Stage IVA Ovari...
Stage IVB Ovari...
Laboratory Biom...
Pembrolizumab
18 Years - Rutgers, The State University of New Jersey View National Cancer Institute "Cancer Moonshot Biobank" NCT04314401 Acute Myeloid L...
Anatomic Stage ...
Anatomic Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Lung Non-Small ...
Lung Small Cell...
Malignant Solid...
Metastatic Pros...
Multiple Myelom...
Stage III Lung ...
Stage III Ovari...
Stage IV Colore...
Stage IV Lung C...
Stage IV Ovaria...
Stage IV Prosta...
Stage IVB Prost...
Biospecimen Col...
Medical Chart R...
13 Years - National Cancer Institute (NCI) View Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer NCT02298959 Clinical Stage ...
Metastatic Colo...
Metastatic Mali...
Metastatic Mela...
Metastatic Ovar...
Metastatic Rena...
Platinum-Resist...
Recurrent Melan...
Recurrent Renal...
Refractory Mela...
Refractory Rena...
Sarcoma
Stage IV Colore...
Stage IV Ovaria...
Stage IV Renal ...
Biopsy
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Pembrolizumab
Ziv-Aflibercept
18 Years - National Cancer Institute (NCI) View A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors NCT03784677 Advanced Malign...
Refractory Mali...
Refractory Ovar...
Refractory Panc...
Stage II Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Ovari...
Stage III Pancr...
Stage III Prost...
Stage IIIA Ovar...
Stage IIIA Pros...
Stage IIIB Ovar...
Stage IIIB Pros...
Stage IIIC Ovar...
Stage IIIC Pros...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IVA Ovari...
Stage IVA Prost...
Stage IVB Ovari...
Stage IVB Prost...
TRPV6 Calcium C...
18 Years - M.D. Anderson Cancer Center View Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer NCT05276973 Fallopian Tube ...
Fallopian Tube ...
Ovarian Endomet...
Ovarian High Gr...
Primary Periton...
Primary Periton...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Unresectable Fa...
Unresectable Fa...
Unresectable Ov...
Unresectable Ov...
Unresectable Pr...
Unresectable Pr...
Biopsy
Carboplatin
Ipatasertib
Paclitaxel
18 Years - National Cancer Institute (NCI) View IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801 Advanced Endome...
Advanced Head a...
Advanced Malign...
Advanced Melano...
Advanced Ovaria...
Chondrosarcoma
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Recurrent Ovari...
Refractory Endo...
Refractory Head...
Refractory Mela...
Refractory Ovar...
Refractory Ovar...
Stage III Ovari...
Stage III Uteri...
Stage IIIA Ovar...
Stage IIIA Uter...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Ovar...
Stage IIIB Uter...
Stage IIIC Ovar...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Ovaria...
Stage IV Uterin...
Stage IVA Ovari...
Stage IVA Uteri...
Stage IVB Ovari...
Stage IVB Uteri...
Bevacizumab
Glutaminase-1 I...
Paclitaxel
Capivasertib
18 Years - M.D. Anderson Cancer Center View Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors NCT04616534 Advanced Fallop...
Advanced Malign...
Advanced Ovaria...
Advanced Pancre...
Advanced Primar...
Fallopian Tube ...
Metastatic Panc...
Ovarian High Gr...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Primary Periton...
Stage II Pancre...
Stage III Fallo...
Stage III Ovari...
Stage III Pancr...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Primar...
Unresectable Pa...
Biopsy
Biospecimen Col...
Diagnostic Imag...
Elimusertib
Gemcitabine
18 Years - National Cancer Institute (NCI) View Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial NCT05554367 Malignant Solid...
Ovarian Low Gra...
Pancreatic Carc...
Stage IV Ovaria...
Stage IV Pancre...
Binimetinib
Biopsy
Biospecimen Col...
Bone Scan
Computed Tomogr...
Magnetic Resona...
Palbociclib
18 Years - National Cancer Institute (NCI) View National Cancer Institute "Cancer Moonshot Biobank" NCT04314401 Acute Myeloid L...
Anatomic Stage ...
Anatomic Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Lung Non-Small ...
Lung Small Cell...
Malignant Solid...
Metastatic Pros...
Multiple Myelom...
Stage III Lung ...
Stage III Ovari...
Stage IV Colore...
Stage IV Lung C...
Stage IV Ovaria...
Stage IV Prosta...
Stage IVB Prost...
Biospecimen Col...
Medical Chart R...
13 Years - National Cancer Institute (NCI) View e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study NCT05786456 Malignant Femal...
Stage III Cervi...
Stage III Ovari...
Stage III Uteri...
Stage III Vagin...
Stage III Vulva...
Stage IV Cervic...
Stage IV Ovaria...
Stage IV Uterin...
Stage IV Vagina...
Stage IV Vulvar...
Discussion
Informational I...
Media Intervent...
Questionnaire A...
Telephone-Based...
18 Years - City of Hope Medical Center View Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors NCT04616534 Advanced Fallop...
Advanced Malign...
Advanced Ovaria...
Advanced Pancre...
Advanced Primar...
Fallopian Tube ...
Metastatic Panc...
Ovarian High Gr...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Primary Periton...
Stage II Pancre...
Stage III Fallo...
Stage III Ovari...
Stage III Pancr...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Primar...
Unresectable Pa...
Biopsy
Biospecimen Col...
Diagnostic Imag...
Elimusertib
Gemcitabine
18 Years - National Cancer Institute (NCI) View Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis NCT03508570 Malignant Perit...
Malignant Retro...
Metastatic Cerv...
Metastatic Endo...
Metastatic Fall...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Peritoneal Carc...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Recurrent Cervi...
Recurrent Endom...
Recurrent Fallo...
Recurrent Malig...
Recurrent Ovari...
Recurrent Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Cervi...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Ipilimumab
Laboratory Biom...
Nivolumab
Pharmacokinetic...
18 Years - M.D. Anderson Cancer Center View Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer NCT02298959 Clinical Stage ...
Metastatic Colo...
Metastatic Mali...
Metastatic Mela...
Metastatic Ovar...
Metastatic Rena...
Platinum-Resist...
Recurrent Melan...
Recurrent Renal...
Refractory Mela...
Refractory Rena...
Sarcoma
Stage IV Colore...
Stage IV Ovaria...
Stage IV Renal ...
Biopsy
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Pembrolizumab
Ziv-Aflibercept
18 Years - National Cancer Institute (NCI) View PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer NCT05465941 Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Biopsy
Pegylated SN-38...
Computed Tomogr...
Biospecimen Col...
18 Years - Mayo Clinic View Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913 Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Hepatobiliary N...
Malignant Diges...
Malignant Femal...
Malignant Genit...
Malignant Neopl...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Stage 0 Colorec...
Stage 0a Bladde...
Stage 0is Bladd...
Stage I Bladder...
Stage I Cervica...
Stage I Colorec...
Stage I Ovarian...
Stage I Prostat...
Stage I Renal C...
Stage I Uterine...
Stage IA Cervic...
Stage IA Ovaria...
Stage IA Uterin...
Stage IA1 Cervi...
Stage IA2 Cervi...
Stage IB Cervic...
Stage IB Ovaria...
Stage IB Uterin...
Stage IB1 Cervi...
Stage IB2 Cervi...
Stage IC Ovaria...
Stage II Bladde...
Stage II Cervic...
Stage II Colore...
Stage II Ovaria...
Stage II Prosta...
Stage II Renal ...
Stage II Uterin...
Stage IIA Cervi...
Stage IIA Color...
Stage IIA Ovari...
Stage IIA Prost...
Stage IIA1 Cerv...
Stage IIA2 Cerv...
Stage IIB Cervi...
Stage IIB Color...
Stage IIB Ovari...
Stage IIB Prost...
Stage IIC Color...
Stage IIC Prost...
Stage III Bladd...
Stage III Cervi...
Stage III Color...
Stage III Ovari...
Stage III Prost...
Stage III Renal...
Stage III Uteri...
Stage IIIA Blad...
Stage IIIA Cerv...
Stage IIIA Colo...
Stage IIIA Ovar...
Stage IIIA Pros...
Stage IIIA Uter...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Blad...
Stage IIIB Cerv...
Stage IIIB Colo...
Stage IIIB Ovar...
Stage IIIB Pros...
Stage IIIB Uter...
Stage IIIC Colo...
Stage IIIC Ovar...
Stage IIIC Pros...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Bladde...
Stage IV Cervic...
Stage IV Colore...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Uterin...
Stage IVA Bladd...
Stage IVA Cervi...
Stage IVA Color...
Stage IVA Ovari...
Stage IVA Prost...
Stage IVA Uteri...
Stage IVB Bladd...
Stage IVB Cervi...
Stage IVB Color...
Stage IVB Ovari...
Stage IVB Prost...
Stage IVB Uteri...
Stage IVC Color...
Patient Monitor...
Questionnaire A...
18 Years - City of Hope Medical Center View Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer NCT03907527 Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Refractory Fall...
Refractory Ovar...
Refractory Prim...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
PRGN-3005 Ultra...
PRGN-3005 Ultra...
18 Years - Precigen, Inc View Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer NCT04067960 Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Biliary Tract C...
Clinical Stage ...
Clinical Stage ...
Malignant Brain...
Malignant Genit...
Malignant Solid...
Pancreatobiliar...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage III Color...
Stage III Ovari...
Stage III Pancr...
Stage III Prost...
Stage IIIA Colo...
Stage IIIA Ovar...
Stage IIIA Pros...
Stage IIIB Colo...
Stage IIIB Ovar...
Stage IIIB Pros...
Stage IIIC Colo...
Stage IIIC Ovar...
Stage IIIC Pros...
Stage IV Colore...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IVA Color...
Stage IVA Ovari...
Stage IVA Pancr...
Stage IVA Prost...
Stage IVB Color...
Stage IVB Ovari...
Stage IVB Pancr...
Stage IVB Prost...
Stage IVC Color...
Biospecimen Col...
Genetic Testing
Quality-of-Life...
Questionnaire A...
- Mayo Clinic View Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients NCT05047926 Advanced Ovaria...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Behavioral Coun...
Nutritional Sup...
Physical Activi...
Survey Administ...
Computed Tomogr...
Biospecimen Col...
Health Educatio...
Medical Device ...
18 Years - Mayo Clinic View Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis NCT03508570 Malignant Perit...
Malignant Retro...
Metastatic Cerv...
Metastatic Endo...
Metastatic Fall...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Peritoneal Carc...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Recurrent Cervi...
Recurrent Endom...
Recurrent Fallo...
Recurrent Malig...
Recurrent Ovari...
Recurrent Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Cervi...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Ipilimumab
Laboratory Biom...
Nivolumab
Pharmacokinetic...
18 Years - M.D. Anderson Cancer Center View Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial NCT04575935 Advanced Ovaria...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Serous ...
Ovarian Transit...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Chemotherapy
Laparotomy
Minimally Invas...
Quality-of-Life...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center View Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT03735589 Stage II Fallop...
Stage II Ovaria...
Stage II Primar...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA Prima...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIB Prima...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Alpha-type-1 Po...
Autologous Natu...
18 Years - Roswell Park Cancer Institute View Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations NCT04550494 Advanced Pancre...
Anatomic Stage ...
Anatomic Stage ...
Castration-Resi...
Clinical Stage ...
Clinical Stage ...
HER2-Positive B...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Metastatic Brea...
Metastatic Gast...
Metastatic Mali...
Metastatic Ovar...
Metastatic Panc...
Metastatic Pros...
Platinum-Sensit...
Stage II Pancre...
Stage III Ovari...
Stage III Pancr...
Stage III Prost...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Biopsy
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Talazoparib
18 Years - National Cancer Institute (NCI) View SMMART Adaptive Clinical Treatment (ACT) Trial NCT05238831 Advanced Breast...
Advanced Malign...
Advanced Ovaria...
Advanced Pancre...
Advanced Prosta...
Advanced Sarcom...
Anatomic Stage ...
Anatomic Stage ...
Recurrent Adult...
Recurrent Breas...
Recurrent Ovari...
Recurrent Prost...
Stage II Pancre...
Stage III Ovari...
Stage III Pancr...
Stage IV Ovaria...
Stage IV Pancre...
Alectinib
Alpelisib
Anastrozole
Atezolizumab
Bevacizumab
Biopsy
Biospecimen Col...
Capecitabine
Carboplatin
Cobimetinib
Entrectinib
Eribulin
Fulvestrant
Hyaluronidase-z...
Irinotecan
Letrozole
Nab-paclitaxel
Niraparib
Olaparib
Paclitaxel
Palbociclib
Pertuzumab
Quality-of-Life...
Trastuzumab
Trastuzumab Emt...
Vemurafenib
Vinorelbine
Vismodegib
18 Years - OHSU Knight Cancer Institute View Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer NCT04498520 Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Hormone Recepto...
Locally Advance...
Metastatic Brea...
Metastatic Endo...
Metastatic Fall...
Metastatic HER2...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Refractory Brea...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVA Uteri...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Abexinostat Tos...
Fulvestrant
Palbociclib
18 Years - University of California, San Francisco View Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery NCT03943173 BRCA-Mutated Ov...
BRCA1 Gene Muta...
BRCA2 Gene Muta...
High Grade Fall...
High Grade Ovar...
Primary Periton...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Chemotherapy
Olaparib
Therapeutic Con...
18 Years - M.D. Anderson Cancer Center View National Cancer Institute "Cancer Moonshot Biobank" NCT04314401 Acute Myeloid L...
Anatomic Stage ...
Anatomic Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Lung Non-Small ...
Lung Small Cell...
Malignant Solid...
Metastatic Pros...
Multiple Myelom...
Stage III Lung ...
Stage III Ovari...
Stage IV Colore...
Stage IV Lung C...
Stage IV Ovaria...
Stage IV Prosta...
Stage IVB Prost...
Biospecimen Col...
Medical Chart R...
13 Years - National Cancer Institute (NCI) View IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801 Advanced Endome...
Advanced Head a...
Advanced Malign...
Advanced Melano...
Advanced Ovaria...
Chondrosarcoma
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Recurrent Ovari...
Refractory Endo...
Refractory Head...
Refractory Mela...
Refractory Ovar...
Refractory Ovar...
Stage III Ovari...
Stage III Uteri...
Stage IIIA Ovar...
Stage IIIA Uter...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Ovar...
Stage IIIB Uter...
Stage IIIC Ovar...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Ovaria...
Stage IV Uterin...
Stage IVA Ovari...
Stage IVA Uteri...
Stage IVB Ovari...
Stage IVB Uteri...
Bevacizumab
Glutaminase-1 I...
Paclitaxel
Capivasertib
18 Years - M.D. Anderson Cancer Center View Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT04095364 Low Grade Fallo...
Ovarian Low Gra...
Primary Periton...
Stage II Fallop...
Stage II Ovaria...
Stage II Primar...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Biopsy
Biospecimen Col...
Carboplatin
Imaging Techniq...
Letrozole
Paclitaxel
18 Years - NRG Oncology View Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer NCT04498520 Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Hormone Recepto...
Locally Advance...
Metastatic Brea...
Metastatic Endo...
Metastatic Fall...
Metastatic HER2...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Refractory Brea...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVA Uteri...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Abexinostat Tos...
Fulvestrant
Palbociclib
18 Years - University of California, San Francisco View Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer NCT02298959 Clinical Stage ...
Metastatic Colo...
Metastatic Mali...
Metastatic Mela...
Metastatic Ovar...
Metastatic Rena...
Platinum-Resist...
Recurrent Melan...
Recurrent Renal...
Refractory Mela...
Refractory Rena...
Sarcoma
Stage IV Colore...
Stage IV Ovaria...
Stage IV Renal ...
Biopsy
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Pembrolizumab
Ziv-Aflibercept
18 Years - National Cancer Institute (NCI) View